Riskpilot← Back to searchSign inGet full accessPOSEIDON KLINIKKEN INTERNATIONAL ApS
APSDissolvedCVR 33255136Vestergade 2B, 2.Ikke-finansielle holdingselskaber · NACE 642020Est. 2010— employees
Revenue 2015
DKK -370K
-559% vs 2014
EBITDA margin
100.0%
-559% vs 2014
Equity ratio
85.7%
Financial strength
Net profit 2015
DKK 2,6M
+2500% vs 2014
| Revenue | DKK -370K | -559% |
| EBITDA | DKK -370K | -559% |
| Net profit | DKK 2,6M | +2500% |
| Total assets | DKK 130K | -48% |
| Equity | DKK 111K | +123% |
| Employees | — | — |
Legal name
POSEIDON KLINIKKEN INTERNATIONAL ApS
CVR number
33255136
Legal form
Anpartsselskab
NACE code
642020 · Ikke-finansielle holdingselskaber
Founded
27. oktober 2010
Share capital
DKK 80.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2015-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en bestyrelse på 3-5 medlemmer. Bestyrelsen kan antage en direktion på 1-2 medlemmer til at varetage selskabets daglige ledelse under ansvar overfor bestyrelsen. Selskabet tegnes af en direktør eller af to bestyrelsesmedlemmer i forening.
Address
Vestergade 2B, 2.
Phone
+4570220225
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 |
|---|---|---|---|---|
| Revenue | -228 | 626 | 81 | -370 |
| Staff expenses | -0 | -0 | -0 | -0 |
| EBITDA | -228 | -808 | 81 | -370 |
| Depreciation & amort. | -59 | -131 | -27 | -0 |
| EBIT | -287 | -938 | 54 | -370 |
| Net financials | -9 | 818 | 169 | 2.930 |
| Profit before tax | -178 | -111 | 222 | 2.561 |
| Tax | 59 | -200 | 329 | -0 |
| Net profit | -237 | 90 | -107 | 2.561 |
| Item | 2012 | 2013 | 2014 | 2015 |
|---|---|---|---|---|
| Total assets | 453 | 579 | 251 | 130 |
| Equity | -473 | -383 | -490 | 111 |
| Long-term debt | 0 | 0 | 0 | 0 |
| Short-term debt | 926 | 962 | 741 | 19 |
| Total debt | 926 | 962 | 741 | 19 |
EBITDA margin
-36967200.0%
This company
15.8%
Market median
-233969720% vs market
20122015
Equity ratio
85.7%
This company
38.2%
Market median
+124% vs market
20122015
Return on equity
2300.5%
This company
18.4%
Market median
+12403% vs market
20122015
Net profit margin
256064100.0%
This company
8.1%
Market median
+3161285085% vs market
20122015
Asset turnover
-2.85×
This company
1.12×
Market median
-354% vs market
20122015
Debt / equity
0.17×
This company
0.62×
Market median
+73% vs market
20122015
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
LP Management | Management | 2010 – 2016 |
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
| Board of Directors | 2012 – 2016 | |
| Board of Directors | 2012 – 2014 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 10–14.99% | 10–14.99% | 2012 | |
| Company | 25–33.32% | 25–33.32% | 2012 | |
| Company | 33.33–49.99% | 33.33–49.99% | 2015 | |
| Individual | 25–33.32% | 25–33.32% | 2012 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of POSEIDON KLINIKKEN INTERNATIONAL ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Priemé | Management | 0 companies |
| Alv Aronson | Board of Directors | 0 companies |
| Christian Knudsen | Board of Directors | 0 companies |